INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $393,069,000 | -69.2% | 19,683 | -64.4% | 0.00% | -78.6% |
| Q1 2021 | $1,277,708,000 | +91.0% | 55,360 | +104.4% | 0.01% | +133.3% |
| Q4 2020 | $669,073,000 | +279846.9% | 27,088 | +612.8% | 0.01% | +50.0% |
| Q1 2020 | $239,000 | -84.8% | 3,800 | -70.1% | 0.00% | -69.2% |
| Q4 2019 | $1,574,000 | +464.2% | 12,696 | +202.3% | 0.01% | +333.3% |
| Q3 2019 | $279,000 | -70.0% | 4,200 | -64.1% | 0.00% | -62.5% |
| Q2 2019 | $930,000 | -26.0% | 11,689 | -6.3% | 0.01% | -33.3% |
| Q4 2018 | $1,257,000 | +5.9% | 12,473 | +32.7% | 0.01% | +71.4% |
| Q3 2018 | $1,187,000 | +30.9% | 9,400 | -36.3% | 0.01% | +40.0% |
| Q1 2018 | $907,000 | -45.9% | 14,746 | -48.6% | 0.01% | -44.4% |
| Q4 2017 | $1,677,000 | +17.8% | 28,700 | +119.1% | 0.01% | -25.0% |
| Q4 2016 | $1,424,000 | +108.8% | 13,100 | +216.3% | 0.01% | +100.0% |
| Q3 2016 | $682,000 | +32.7% | 4,142 | +15.1% | 0.01% | +20.0% |
| Q2 2016 | $514,000 | +26.9% | 3,600 | +14.1% | 0.01% | +25.0% |
| Q1 2016 | $405,000 | -73.6% | 3,154 | -50.4% | 0.00% | -80.0% |
| Q2 2015 | $1,536,000 | +231.7% | 6,363 | +287.3% | 0.02% | +233.3% |
| Q1 2015 | $463,000 | -91.3% | 1,643 | -95.2% | 0.01% | -90.5% |
| Q4 2014 | $5,329,000 | -8.7% | 34,161 | +38.5% | 0.06% | +1.6% |
| Q2 2014 | $5,838,000 | – | 24,673 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |